HAYWARD, Calif. - Benitec Biopharma Inc. (NASDAQ: BNTC), a biotechnology company focused on gene therapy with a market capitalization of $364 million and an impressive 206% return over the past year, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback